Skip to main content

Table 2 Association of clinicopathological parameters and PODXL expression by polyclonal and monoclonal antibodies combined

From: A comparative study of two PODXL antibodies in 840 colorectal cancer patients

  PODXL expression
  Low Moderate High  
n (%) 714 (88.4) 79 (9.8) 14 (1.7) p-value
Age, years     
<65 300 (42.0) 38 (48.1) 5 (35.7) 0.643
≥ 65 414 (58.0) 41 (51.9) 9 (64.3)  
Gender     
Male 398 (55.7) 41 (51.9) 7 (50.0) 0.450
Female 316 (44.3) 38 (48.1) 7 (50.0)  
Dukes     
A 113 (15.8) 4 (5.1) 0 (0.0) < 0.0001
B 257 (36.0) 26 (32.9) 2 (14.3)  
C 187 (26.2) 32 (40.5) 2 (14.3)  
D 157 (22.0) 17 (21.5) 10 (71.4)  
Grade (WHO)     
1 28 (3.9) 0 (0.0) 0 < 0.0001
2 513 (72.4) 32 (40.5) 3 (21.4)  
3 149 (21.0) 37 (46.8) 9 (64.3)  
4 19 (2.7) 10 (12.7) 2 (14.3)  
Missing 5    
Location     
Colon 362 (50.7) 49 (62.0) 7 (50.0) 0.168
Rectum 352 (49.3) 30 (38.0) 7 (50.0)  
Side     
Right 185 (25.9) 32 (40.5) 6 (42.9) 0.003
Left 529 (74.1) 47 (59.5) 8 (57.1)  
Histology     
Adenomatous 639 (89.6) 70 (88.6) 13 (92.9) 0.879
Mucinous 74 (10.4) 9 (11.4) 1 (7.1)  
Missing 1    
  1. Linear-by-linear association test was used for this table. Missing data is not included in the analyses.